SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-619606
Filing Date
2016-06-13
Accepted
2016-06-13 07:54:05
Documents
5
Period of Report
2016-06-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d135874d8k.htm 8-K 35400
2 EX-10.1 d135874dex101.htm EX-10.1 471407
3 EX-99.1 d135874dex991.htm EX-99.1 11963
4 EX-99.2 d135874dex992.htm EX-99.2 7324
5 GRAPHIC g135874g61o46.jpg GRAPHIC 8708
  Complete submission text file 0001193125-16-619606.txt   539442
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 161709886
SIC: 2834 Pharmaceutical Preparations